03558
Poly(methyl methacrylate)
analytical standard, 2,480,000
Sinónimos:
PMMA, Poly(methacrylic acid methyl ester)
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula lineal:
[CH2C(CH3)(CO2CH3)]n
Número CAS:
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.24
MDL number:
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarlegrade
analytical standard
Quality Level
autoignition temp.
580 °F
shelf life
limited shelf life, expiry date on the label
mol wt
Mn ~2140000, Mp ~2740000, Mw ~2480000
technique(s)
gel permeation chromatography (GPC): suitable
solubility
H2O: insoluble
density
1.200 g/cm3
Mw/Mn
~1.16
storage temp.
2-8°C
InChI
1S/C5H9O2/c1-4(2)5(6)7-3/h1-3H3
InChI key
PMAMJWJDBDSDHV-UHFFFAOYSA-N
General description
Poly(methyl methacrylate) is a material, which can be used in the fabrication of micro-fluid chips. It can also find applications in nano-transfer printing, since it can act like a macroscopic mediator in order to handle nanoscale building blocks.
Clase de almacenamiento
11 - Combustible Solids
wgk
nwg
ppe
Eyeshields, Gloves, type N95 (US)
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Creation of nanostructures with poly (methyl methacrylate)-mediated nanotransfer printing
Jiao L, et al.
Journal of the American Chemical Society, 130, 12612-12613 (2008)
Development and spectral characterization of poly (methyl methacrylate)/hydroxyapatite composite for biomedical applications
Chen Y, et al.
Development and spectral characterization of poly (methyl methacrylate)/hydroxyapatite composite for biomedical applications, 18(1), 41-45 (2004)
Bo Chen et al.
Journal of controlled release : official journal of the Controlled Release Society, 140(3), 203-209 (2009-05-26)
Water-soluble polymers for the delivery of chemotherapeutic drugs passively target solid tumors as a consequence of reduced renal clearance and the enhanced permeation and retention (EPR) effect. Elimination of the polymers in the kidney occurs due to filtration through biological